Nootropics Index - Save on smarter supplements
Nootropics>Amino acids & derivatives>Betaine
Amino acids & derivatives

Betaine

Betaine anhydrous / trimethylglycine (TMG)

Betaine anhydrous, also called trimethylglycine (TMG), is a methyl donor and osmolyte. It should not be merged with betaine HCl, which is sold for a different digestive-acid use case. Human evidence is strongest for homocysteine biomarker changes and selected exercise-performance outcomes, not healthy-adult memory, focus, mood, or nootropic enhancement. When comparing products, verify the exact form, grams per serving, powder versus capsules, and available quality documentation; do not compare TMG with HCl by price alone.

Physical PerformanceEnduranceStrength PowerGlucose MetabolismMethylation SupportClinical ResearchLimited Human Evidence
Updated August 2026/6 min read/7 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

Two common forms lead to different decisions

1

Betaine usually means betaine anhydrous or TMG when people discuss methyl donation and homocysteine. Betaine HCl is a hydrochloride form sold for a different digestive-acid use case. These forms should not be compared only by price per gram.

Best evidence is not nootropic evidence

3

Human evidence is strongest around plasma homocysteine response and some exercise-performance measures. The nootropic case is indirect: methylation biology and homocysteine changes do not establish healthy-adult cognitive enhancement.

Homocysteine biomarker context3
Human trials and evidence syntheses report that betaine can lower plasma homocysteine. This is a biomarker change, not a guarantee of cardiovascular benefit or a reason to use a medical treatment dose as a retail-supplement target.
Exercise-performance context5
A 2024 exercise meta-analysis found selected strength and jump-performance signals after chronic betaine use, while other upper-body, sprint, and endurance outcomes were not consistently improved.
02

Names, aliases and forms

Common NameBetaine
Chemical NamesTrimethylglycine; Glycine betaine
AbbreviationTMG
Freebase FormBetaine anhydrous
03

Mechanisms of action

Mechanism to understand

1

Betaine acts as an osmolyte and as a methyl donor in the methionine cycle, especially in liver and kidney metabolism. That mechanism supports biomarker research, but it does not prove acute focus, mood, or memory enhancement.

04

Potential effects and evidence map

Grade C for practical supplement context but Grade D for direct nootropic use: human data support homocysteine changes and mixed performance outcomes, while cognition, focus, and mood claims remain indirect.

Effect domainMagnitudeGrade
Physical energy / endurance5
CumulativeConfidence: Medium

Chronic betaine supplementation has mixed but plausible evidence for selected strength or power outcomes, especially lower-body measures, not broad endurance or cognitive energy.

Note Exercise-performance evidence should not be converted into nootropic claims.

2/5
C
Mental energy / wakefulness1
UnknownConfidence: Medium

Betaine is not established as an acute mental-energy or wakefulness supplement for healthy adults.

Note Methylation and osmolyte mechanisms are indirect for user-perceived energy.

0/5
E
Focus / attention1
UnknownConfidence: Medium

There is no reliable direct evidence that betaine improves focus or attention in healthy adults.

Note Avoid repeating legacy cognitive-performance framing.

0/5
E
Mood / wellbeing3
UnknownConfidence: Low

Mood support claims are indirect and should not be presented as a proven effect.

Note Homocysteine or methylation context does not establish mood benefit.

0/5
E
05

Typical dosages and timing

Healthy-adult study context34-6 g/day

The cited healthy-adult meta-analysis evaluated 4-6 g/day for 6-24 weeks and found a plasma-homocysteine reduction. This is research context, not a general retail-supplement recommendation: study amounts and outcomes differ, and prescription betaine anhydrous is a separate physician-managed context. Do not use a prescription dose or a betaine HCl label to choose a TMG amount.

06

Timing & effect horizon

Effect horizonCumulative
Cumulative
Study window3Cumulative
6-24 weeks
Repeated-use study context3

The cited healthy-adult homocysteine meta-analysis evaluated repeated daily use for 6-24 weeks. This is study duration, not an acute effect duration or a recommended cycle.

07

Safety, side effects and risk profile

Low base risk; form and dose still matter4
For generally healthy adults using oral TMG, the base risk is low. The next lower minimal label is not sufficient because doses of 4 g/day or more, still within the research range, were associated with higher total and LDL cholesterol in a meta-analysis. That high-dose lipid finding is a targeted caution, not evidence that lower-dose TMG or betaine HCl share the same risk profile.
GI discomfort6
Confidence: Medium

Nausea, gastrointestinal distress, diarrhea, and odor were reported in a physician survey of prescription betaine anhydrous for homocystinuria. That medical population and dose context cannot estimate event rates for retail TMG or betaine HCl.

Note Low tolerability concern in this profile; keep the label signal in its medical context without transferring its rate across forms.

1/5
C
Cardiovascular caution4
Confidence: Medium

At doses of 4 g/day or more, the cited meta-analysis associated betaine supplementation with higher total and LDL cholesterol. It did not establish a cardiovascular outcome effect.

Note Targeted high-dose lipid caution; it does not by itself support a moderate base-risk label for ordinary oral TMG.

2/5
B
Liver / kidney caution6
Confidence: Medium

The cited sources do not establish a routine liver or kidney concern for retail TMG. Prescription betaine anhydrous use for homocystinuria is a separate medical context.

Note Do not transfer medical-label monitoring to retail TMG without form- and condition-specific evidence.

0/5
D
Interaction risk1
Confidence: Medium

The sources used here do not establish a form-specific drug-interaction claim for retail TMG or betaine HCl. This is an evidence limit, not evidence that no interaction can occur.

Note Keep TMG, HCl, and prescription betaine anhydrous evidence separate when reviewing labels and medication questions.

0/5
D
Pregnancy / lactation caution7
Confidence: Medium

Pregnancy or breastfeeding use should stay within clinician-guided nutrition or medical context rather than high-dose self-directed supplementation.

Note No nootropic indication justifies casual high-dose use.

2/5
C
Evidence uncertainty4
Confidence: High

Evidence is form- and endpoint-specific; TMG, betaine HCl, homocysteine, exercise, and nootropic claims should not be blended.

Note Evidence uncertainty should limit claims, not inflate the healthy-adult base-risk label.

1/5
B
Medical-label context6GI symptoms and odor

In a physician survey of prescription betaine anhydrous treatment, nausea, gastrointestinal distress, diarrhea, and odor were reported. This medical population and dose context does not establish retail-supplement rates, but troubling symptoms warrant review rather than automatic dose escalation.

08

Interactions and cautions

Do not treat HCl as TMG1

A product labeled betaine HCl is not a substitute for TMG or betaine anhydrous in methyl-donor or homocysteine research. Medical betaine anhydrous use and homocysteine monitoring should remain clinician-supervised. Review the exact product label and your medication regimen with a pharmacist or clinician rather than transferring research, dose, or tolerance expectations between forms.

09

Legal and regulatory status

United States, as of 20267

As of 2026, FDA explains that dietary supplements are regulated as a category but are not approved for safety or effectiveness before marketing. That general U.S. framework does not make retail TMG or betaine HCl products equivalent to prescription betaine anhydrous, and it does not establish legal status in other jurisdictions.

10

How it compares

Betaine / TMG1

Betaine overlaps with methylation and one-carbon metabolism discussions, but it is not the same buying decision as folate, B12, choline donors, SAMe, or creatine. Check the goal and form before counting stacks as substitutes.

11

Practical buying and quality notes

  • Compare betaine anhydrous, trimethylglycine, TMG, or glycine betaine only with the same identity. Betaine HCl is a different digestive-acid product context and is not a direct TMG price or dose comparison.1
  • For methyl-donor or homocysteine context, look for betaine anhydrous, trimethylglycine, TMG, or glycine betaine. For digestive-acid products, labels usually say betaine HCl or hydrochloride. Do not mix those pools when sorting by price.1
  • Check the active-ingredient label, grams per serving, capsule count or powder amount, and whether the product names betaine anhydrous/TMG or betaine HCl. Only compare package size and price after that identity check.1
  • Offer rows can help compare listed prices only after you match the exact ingredient form and amount. A lower price, capsule format, or betaine HCl label does not establish a nootropic or cardiovascular benefit; assess TMG evidence separately for the outcome you care about.1
12

References

  1. Craig SA. Betaine in human nutrition. Am J Clin Nutr. 2004.
  2. Steenge GR, Verhoef P, Katan MB. Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr. 2003.
  3. McRae MP. Betaine supplementation decreases plasma homocysteine in healthy adult participants: a meta-analysis. J Chiropr Med. 2013.
  4. Ashtary-Larky D, Bagheri R, Ghanavati M, et al. Effects of betaine supplementation on cardiovascular markers: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2022.
  5. Zawieja E, Machek S, Zanchi NE, Cholewa J, Wozniewicz M. Effects of chronic betaine supplementation on exercise performance: systematic review and meta-analysis. J Sports Sci. 2024.
  6. DailyMed. Betaine anhydrous for oral solution label.
  7. U.S. FDA. Information for Consumers on Using Dietary Supplements.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.